You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Oct. 9, 2018 /PRNewswire/ -- Astellas today issued its third-annual Americas Corporate Social Responsibility (CSR) Report Card. The Report Card, which can be found here, outlines the company's progress made during Fiscal Year 2017 to fulfill its commitments to patients, employees and the communities where we work and live.
"At Astellas, our commitment to improving the lives of others is at the core of what we do. We strive to be kind to one another, the community and the environment," said Percival Barretto-Ko, president, Astellas Americas. "I'm proud of our team's efforts and I am pleased to share our progress in key focus areas in our 2017 CSR Report Card. I look forward to building on this momentum and continuing to help those in need."
Astellas is committed to operating in a socially responsible manner to make a positive impact in the communities around the world. By outlining its progress over the past year, Astellas is better positioned to continue its evolution as an industry-leading, responsible and sustainable company.
Highlights
The Americas CSR Report Card captures multiple measures including:
Astellas Awards and Recognition
Astellas' focus on sustainability in the Americas has resulted in a number of awards including:
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
SOURCE Astellas
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.